+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oncology Companion Diagnostics"

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

  • Report
  • August 2023
  • 1500 Pages
  • Global
From
Oncology Companion Diagnostic Market Size, Share & Trends Analysis Report By Product & Service, By Technology (IHC, NGS), By Disease Type (Breast Cancer, Leukemia), By End Use, By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Oncology Companion Diagnostic Market Size, Share & Trends Analysis Report By Product & Service, By Technology (IHC, NGS), By Disease Type (Breast Cancer, Leukemia), By End Use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 183 Pages
  • Global
From
Oncology Companion Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F - Product Thumbnail Image

Oncology Companion Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

  • Report
  • November 2023
  • 179 Pages
  • Global
From
United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition - Product Thumbnail Image

United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition

  • Report
  • October 2022
  • 220 Pages
  • United States
From
The World Market for Cancer Diagnostics, 2021 - Product Thumbnail Image

The World Market for Cancer Diagnostics, 2021

  • Report
  • December 2021
  • 347 Pages
  • Global
From
Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities - Product Thumbnail Image

Companion Diagnostics in the COVID-19 Era: Market Analysis and Opportunities

  • Report
  • June 2020
  • 180 Pages
  • Global
From
U.S. Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Fine-needle Aspiration, Core, Surgical, Skin Biopsy/Punch Biopsy), By Application, By Site, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

U.S. Cancer Biopsy Market Size, Share & Trends Analysis Report By Type (Fine-needle Aspiration, Core, Surgical, Skin Biopsy/Punch Biopsy), By Application, By Site, And Segment Forecasts, 2023 - 2030

  • Report
  • January 2023
  • 155 Pages
  • United States
From
Companion Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Companion Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 120 Pages
  • Global
From
  • 8 Results (Page 1 of 1)
Loading Indicator

Oncology Companion Diagnostics (OCD) are a type of diagnostic test used to identify and monitor cancer patients. These tests are used to detect the presence of cancer, determine the type of cancer, and assess the patient's response to treatment. OCDs are used to identify genetic mutations that may be associated with the development of cancer, as well as to identify biomarkers that can be used to predict the risk of cancer recurrence. OCDs are also used to monitor the progression of cancer and to determine the effectiveness of treatment. OCD tests are typically performed in conjunction with other diagnostic tests, such as imaging and biopsy. They are used to provide a more comprehensive picture of the patient's cancer and to guide treatment decisions. Companies in the Oncology Companion Diagnostics market include Roche, Illumina, Thermo Fisher Scientific, Agilent Technologies, and Qiagen. Show Less Read more